Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: A prospective, randomized, multicenter study

American Journal of Transplantation

Volumn 13, Issue 1, 2013, Pages 136-145

  Hirsch, H H ^a,b   Vincenti, F ^c   Friman, S ^d   Tuncer, M ^e   Citterio, F ^f   Wiecek, A ^g   Scheuermann, E H ^h   Klinger, M ⁱ   Russ, G ^j   Pescovitz, M D ^k   Prestele, H ^l  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e MEDICAL PARK HOSPITAL   (Turkey)

^f CATHOLIC UNIVERSITY   (Italy)

^g MEDICAL UNIVERSITY OF SILESIA   (Poland)

^h UNIVERSITY HOSPITAL FRANKFURT   (Germany)

ⁱ WROCLAW MEDICAL UNIVERSITY   (Poland)

^j QUEEN ELIZABETH HOSPITAL   (Australia)

^k INDIANA UNIVERSITY   (United States)

^l NOVARTIS PHARMA AG   (Switzerland)

more..

Author keywords

BK virus; cyclosporine; immunosuppression; polyomavirus; risk factor; steroids; tacrolimus; transplantation

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; AGE; ARTICLE; BK VIRUS; BK VIRUS INFECTION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

ADULT; BK VIRUS; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACROLIMUS; VIRUS REPLICATION;

EID: 84871718037     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04320.x     Document Type: Article

References (36)

1. Randhawa PS, Finkelstein S, Scantlebury V, et al.. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103-109.
2. Binet I, Nickeleit V, Hirsch HH, et al.. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918-922.
3. Ramos E, Drachenberg CB, Wali R, Hirsch HH,. The decade of polyomavirus BK-associated nephropathy: State of affairs. Transplantation 2009; 87: 621-630.
4. Ramos E, Drachenberg CB, Papadimitriou JC, et al.. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145-2151.
5. Hirsch HH, Brennan DC, Drachenberg CB, et al.. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277-1286.
6. Wadei HM, Rule AD, Lewin M, et al.. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant 2006; 6 (5 Pt 1): 1025-1032.
7. Dharnidharka VR, Cherikh WS, Abbott KC,. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation. 2009; 87: 1019-1026.
8. Schold JD, Rehman S, Kayler LK, Magliocca J, Srinivas TR, Meier-Kriesche HU,. Treatment for BK virus: Incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int 2009; 22: 626-634.
9. Hirsch HH, Knowles W, Dickenmann M, et al.. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488-496.
10. Nickeleit V, Klimkait T, Binet IF, et al.. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309-1315.
11. Brennan DC, Agha I, Bohl DL, et al.. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582-594.
12. Viscount HB, Eid AJ, Espy MJ, et al.. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation 2007; 84: 340-345.
13. Ginevri F, Azzi A, Hirsch HH, et al.. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007; 7: 2727-2735.
14. Schaub S, Hirsch, HH, Dickenmann, M, et al.. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus- associated nephropathy. Am J Transplant 2010; 10: 2615-2623.
15. Kasiske BL ZM, Craig JC, Ekberg H, et al.. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9 (Suppl 3): S1-S155.
16. Hirsch HH, Randhawa P,. BK virus in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S136-S146.
17. Hirsch HH, Steiger J,. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611-623.
18. Egli A, Infanti L, Dumoulin A, et al.. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009; 199: 837-846.
19. Meier-Kriesche HU, Li S, Gruessner RW, et al.. Immunosuppression: Evolution in practice and trends, 1994-2004. Am J Transplant 2006; 6 (5 Pt 2): 1111-1131.
20. Manitpisitkul W, Drachenberg C, Ramos E, et al.. Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: A case-control study. Transplantation 2009; 88: 83-88.
21. Ramos E, Drachenberg CB, Portocarrero M, et al.. BK virus nephropathy diagnosis and treatment: Experience at the University of Maryland Renal Transplant Program. Clin Transplant 2002: 143-153.
22. Vincenti F, Friman S, Scheuermann E, et al.. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007; 7: 1506-1514.
23. Hirsch HH, Mohaupt M, Klimkait T,. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis 2001; 184: 1494-1495; author reply 5-6.
24. Funk GA, Gosert R, Comoli P, Ginevri F, Hirsch HH,. Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants. Am J Transplant 2008; 8: 2368-2377.
25. Dadhania D, Snopkowski C, Ding R, et al.. Epidemiology of BK virus in renal allograft recipients: Independent risk factors for BK virus replication. Transplantation 2008; 86: 521-528.
26. Gosert R, Rinaldo CH, Funk GA, et al.. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J Exp Med 2008; 205: 841-852.
27. Khamash HA, Wadei HM, Mahale AS, et al.. Polyomavirus-associated nephropathy risk in kidney transplants: The influence of recipient age and donor gender. Kidney Int 2007; 71: 1302-1309.
28. Arns W, Breuer S, Choudhury S, et al.. Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil. Clin Transplant 2005; 19: 199-206.
29. Koukoulaki M, Grispou E, Pistolas D, et al.. Prospective monitoring of BK virus replication in renal transplant recipients. Transpl Infect Dis 2009; 11: 1-10.
30. Funk GA, Steiger J, Hirsch HH,. Rapid dynamics of polyomavirus type BK in renal transplant recipients. J Infect Dis 2006; 193: 80-87.
31. Li YJ, Weng CH, Lai WC, et al.. A suppressive effect of cyclosporine A on replication and noncoding control region activation of polyomavirus BK virus. Transplantation 2010; 89: 299-306.
32. Acott PD, O'Regan PA, Lee SH, Crocker JF,. In vitro effect of cyclosporin A on primary and chronic BK polyoma virus infection in Vero E6 cells. Transpl Infect Dis 2008; 10: 385-390.
33. Acott P, O'Regan PA, Crocker JF,. Suppression of early and chronic BK polyoma virus replication by mycophenolic acid in Vero cells. Transpl Int 2009; 22: 225-231.
34. Hirsch HH, Min L, Wernli M,. Polyomavirus BK (BKV) replication in renal tubular epithelial cells is inhibited by mTOR inhibitors, but activated by tacrolimus in a pathway involving the FKBP12 (Abstract #497; Accepted for Oral Presentation at the 11th ATC 2011). Am J Transplant 2011; 11-179.
35. Fishman JA, Rubin RH,. Infection in organ-transplant recipients. N Engl J Med. 1998; 338: 1741-1751.
36. Comoli P, Hirsch HH, Ginevri F,. Cellular immune responses to BK virus. Curr Opin Organ Transplant 2008; 13: 569-574.